Bovie Medical Co. (NYSEAMERICAN:BVX) saw a significant growth in short interest during the month of December. As of December 29th, there was short interest totalling 406,797 shares, a growth of 6.5% from the December 15th total of 382,005 shares. Approximately 1.4% of the shares of the company are sold short. Based on an average daily volume of 123,521 shares, the days-to-cover ratio is currently 3.3 days.

Shares of Bovie Medical (NYSEAMERICAN:BVX) traded down $0.02 during mid-day trading on Wednesday, hitting $2.51. The company had a trading volume of 59,400 shares, compared to its average volume of 77,133. The company has a market capitalization of $84.78, a PE ratio of -15.69 and a beta of -0.57. Bovie Medical has a fifty-two week low of $1.87 and a fifty-two week high of $4.29.

Several hedge funds have recently modified their holdings of BVX. RTW Investments LP bought a new stake in shares of Bovie Medical in the third quarter valued at approximately $3,852,000. Raymond James Financial Services Advisors Inc. bought a new stake in shares of Bovie Medical in the second quarter valued at approximately $199,000. Archon Capital Management LLC bought a new stake in shares of Bovie Medical in the third quarter valued at approximately $254,000. Perkins Capital Management Inc. boosted its stake in shares of Bovie Medical by 4.0% in the third quarter. Perkins Capital Management Inc. now owns 623,685 shares of the medical device company’s stock valued at $2,108,000 after buying an additional 23,868 shares during the period. Finally, Virtu KCG Holdings LLC boosted its stake in shares of Bovie Medical by 23.5% in the second quarter. Virtu KCG Holdings LLC now owns 42,941 shares of the medical device company’s stock valued at $106,000 after buying an additional 8,182 shares during the period.

Several equities analysts have recently commented on BVX shares. Zacks Investment Research raised Bovie Medical from a “sell” rating to a “hold” rating in a research report on Monday, October 16th. ValuEngine downgraded Bovie Medical from a “hold” rating to a “sell” rating in a research report on Monday, November 6th.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2018/01/10/short-interest-in-bovie-medical-co-bvx-rises-by-6-5.html.

About Bovie Medical

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.